Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature

Autor Balena, R, Hensley, I E, Miller, S, Barnett, A H
Vydáno 2013

Safety and tolerability of high doses of taspoglutide, a once-weekly human GLP-1 analogue, in diabetic patients treated with metformin: a randomized double-blind placebo-controlled...

Autor Ratner, R, Nauck, M, Kapitza, C, Asnaghi, V, Boldrin, M, Balena, R
Vydáno 2010

Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.

Autor Poli, V, Balena, R, Fattori, E, Markatos, A, Yamamoto, M, Tanaka, H, Ciliberto, G, Rodan, G A, Costantini, F
Vydáno 1994

Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in minipigs. A one-year study.

Autor Lafage, M H, Balena, R, Battle, M A, Shea, M, Seedor, J G, Klein, H, Hayes, W C, Rodan, G A
Vydáno 1995

The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.

Autor Balena, R, Toolan, B C, Shea, M, Markatos, A, Myers, E R, Lee, S C, Opas, E E, Seedor, J G, Klein, H, Frankenfield, D
Vydáno 1993